Randomized Open-label Study Comparing 2 Different Strategies For Management Of Subjects With Plaque Psoriasis Who Have Responded To Etanercept Treatment
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2016
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms ReSPONSE
- Sponsors Pfizer
- 01 Feb 2016 Last checked against ClinicalTrials.gov record.
- 14 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2013 Planned End Date changed from 1 May 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.